Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
AstraZeneca
Biotech
AstraZeneca adds FDA cell and gene veteran—Chutes & Ladders
AstraZeneca adds FDA cell and gene veteran. Corrixr founder passes baton to new CEO. Capricor brings in DMD veteran to lead commercial launch.
Darren Incorvaia
,
Zoey Becker
,
Will Maddox
Jun 5, 2026 8:30am
Fierce Pharma
Lilly, Boehringer slash investment plans in Germany
Jun 3, 2026 3:10pm
ASCO: BMS' bispecific ADC puts TROP2 drugs on notice
Jun 2, 2026 8:00am
AstraZeneca, after phase 3 miss, posts data behind approval bid
May 29, 2026 10:15am
FDA delays ruling on AstraZeneca drug after negative adcomm vote
May 27, 2026 4:43am
AstraZeneca pens agentic AI licensing deal with Owkin
May 13, 2026 2:06am